Fjölmiðlaumfjöllun
15
Fjölmiðlaumfjöllun
Titill With 80,000 Participants, The Largest Study Of Its Kind Is The First To Evaluate The Benefits Of Screening For A Precursor To The Blood Cancer Multiple Myeloma Heiti/miðill fjölmiðla TheStreet.com Land/Yfirráðasvæði Bandaríkin Dagsetning 19/05/21 URL https://www.thestreet.com/press-releases/with-80-000-participants-the-largest-study-of-its-kind-is-the-first-to-evaluate-the-benefits-of-screening-for-a-precursor-to-the-blood-cancer-multiple-myeloma-15659371 Aðilar Sigurður Yngvi Kristinsson Titill With 80,000 Participants, the Largest Study of Its Kind Is the First to Evaluate the Benefits of Screening for a Precursor to the Blood Cancer Multiple Myeloma Heiti/miðill fjölmiðla Morningstar.com Land/Yfirráðasvæði Bandaríkin Dagsetning 19/05/21 URL https://www.morningstar.com/news/pr-newswire/20210519dc82425/with-80000-participants-the-largest-study-of-its-kind-is-the-first-to-evaluate-the-benefits-of-screening-for-a-precursor-to-the-blood-cancer-multiple-myeloma Aðilar Sigurður Yngvi Kristinsson Titill With 80,000 Participants, the Largest Study of Its Kind Is the First to Evaluate the Benefits of Screening for a Precursor to the Blood Cancer Multiple Myeloma; -The Iceland Screens, Treats, or Prevents Multiple Myeloma study (iStopMM) is the first to eva Heiti/miðill fjölmiðla PR Newswire Land/Yfirráðasvæði Bandaríkin Dagsetning 19/05/21 Aðilar Sigurður Yngvi Kristinsson Titill With 80,000 Participants, the Largest Study of Its Kind Is the First to Evaluate the Benefits of Screening for a Precursor to the Blood Cancer Multiple Myeloma Heiti/miðill fjölmiðla Finanzen.net Land/Yfirráðasvæði Þýskaland Dagsetning 19/05/21 URL https://www.finanzen.net/nachricht/aktien/with-80-000-participants-the-largest-study-of-its-kind-is-the-first-to-evaluate-the-benefits-of-screening-for-a-precursor-to-the-blood-cancer-multiple-myeloma-10153065 Aðilar Sigurður Yngvi Kristinsson Titill With 80,000 Participants, the Largest Study of Its Kind Is the First to Evaluate the Benefits of Screening for a Precursor to the Blood Cancer Multiple Myeloma Heiti/miðill fjölmiðla Yahoo! Finance Land/Yfirráðasvæði Bandaríkin Dagsetning 19/05/21 URL https://finance.yahoo.com/news/80-000-participants-largest-study-094500940.html Aðilar Sigurður Yngvi Kristinsson Titill With 80,000 Participants, the Largest Study of Its Kind Is the First to Evaluate the Benefits of Screening for a Precursor to the Blood Cancer Multiple Myeloma Heiti/miðill fjölmiðla ProfitQuotes.com Land/Yfirráðasvæði Bandaríkin Dagsetning 19/05/21 URL www.profitquotes.com/cgi/?a=news&ticker=a&w=&story=202105202105190545PR_NEWS_USPR_____DC82425 Aðilar Sigurður Yngvi Kristinsson Titill With 80,000 Participants, the Largest Study of... Heiti/miðill fjölmiðla ADVFN Deutschland Land/Yfirráðasvæði Þýskaland Dagsetning 19/05/21 URL https://de.advfn.com/p.php?pid=nmona&article=85154726 Aðilar Sigurður Yngvi Kristinsson Titill With 80,000 Participants, the Largest Study of Its Kind Is the First to Evaluate the Benefits of Screening for a Precursor to the Blood Cancer Multiple Myeloma Heiti/miðill fjölmiðla Yahoo! Finanzas Land/Yfirráðasvæði Bandaríkin Dagsetning 19/05/21 URL https://es-us.finanzas.yahoo.com/news/80-000-participants-largest-study-094500940.html Aðilar Sigurður Yngvi Kristinsson Titill With 80,000 Participants, the Largest Study of Its Kind Is the First to Evaluate the Benefits of Screening for a Precursor to... Heiti/miðill fjölmiðla ADVFN US Land/Yfirráðasvæði Bandaríkin Dagsetning 19/05/21 URL https://www.advfn.com/p.php?pid=nmona&article=85154726 Aðilar Sigurður Yngvi Kristinsson Titill With 80,000 Participants, the Largest Study of Its Kind Is the First to Evaluate the Benefits of Screening for a Precursor to the Blood Cancer Multiple Myeloma Heiti/miðill fjölmiðla TickerTech.com Land/Yfirráðasvæði Bandaríkin Dagsetning 19/05/21 URL www.tickertech.com/cgi/?a=news&ticker=a&w=&story=202105202105190545PR_NEWS_USPR_____DC82425 Aðilar Sigurður Yngvi Kristinsson Titill With 80,000 Participants, the Largest Study of Its Kind Is the First to Evaluate the Benefits of Screening for a Precursor to the Blood Cancer Multiple Myeloma Heiti/miðill fjölmiðla Yahoo! News Land/Yfirráðasvæði Bandaríkin Dagsetning 19/05/21 URL https://www.yahoo.com/now/80-000-participants-largest-study-094500940.html Aðilar Sigurður Yngvi Kristinsson Titill With 80,000 Participants, the Largest Study of Its Kind Is the First to Evaluate the Benefits of Screening for a Precursor to the Blood Cancer Multiple Myeloma Heiti/miðill fjölmiðla Finanzen.ch Land/Yfirráðasvæði Sviss Dagsetning 19/05/21 URL https://www.finanzen.ch/nachrichten/aktien/with-80-000-participants-the-largest-study-of-its-kind-is-the-first-to-evaluate-the-benefits-of-screening-for-a-precursor-to-the-blood-cancer-multiple-myeloma-1030445303 Aðilar Sigurður Yngvi Kristinsson Titill With 80,000 Participants, the Largest Study of Its Kind Is the First to Evaluate the Benefits of Screening for a Precursor to the Blood Cancer Multiple Myeloma Heiti/miðill fjölmiðla Spoke.com Land/Yfirráðasvæði Bandaríkin Dagsetning 19/05/21 URL https://www.spoke.com/press_releases/60a4e49d305335cc2200f818 Aðilar Sigurður Yngvi Kristinsson Titill With 80,000 Participants, the Largest Study of Its Kind Is the First to Evaluate the Benefits of Screening for a Precursor to the Blood Cancer Multiple Myeloma Heiti/miðill fjölmiðla WFMZ-TV Online Land/Yfirráðasvæði Bandaríkin Dagsetning 19/05/21 URL https://www.wfmz.com/news/pr_newswire/pr_newswire_health/with-80-000-participants-the-largest-study-of-its-kind-is-the-first-to-evaluate/article_d4269f91-d187-578d-8b0c-e78772004ae8.html Aðilar Sigurður Yngvi Kristinsson Titill With 80,000 Participants, the Largest Study of Its Kind Is the First to Evaluate the Benefits of Screening for a Precursor to the Blood Cancer Multiple Myeloma Heiti/miðill fjölmiðla VB Profiles Land/Yfirráðasvæði Bandaríkin Dagsetning 19/05/21 URL https://www.vbprofiles.com/press_releases/60a4deb39490496bba4f9236 Aðilar Sigurður Yngvi Kristinsson